GLUCOCORTICOID-INDUCED OSTEOPOROSIS
Clinical trials for GLUCOCORTICOID-INDUCED OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new GLUCOCORTICOID-INDUCED OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for GLUCOCORTICOID-INDUCED OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone drug showdown: which works better for Steroid-Weakened bones?
Disease control CompletedThis study looked at two osteoporosis medications—romosozumab and denosumab—in 54 people who take long-term steroids and have weak bones. Participants first received either romosozumab for 12 months followed by denosumab, or denosumab alone for 24 months. Then everyone stayed on …
Matched conditions: GLUCOCORTICOID-INDUCED OSTEOPOROSIS
Phase: PHASE4 • Sponsor: Tuen Mun Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Best way to switch osteoporosis meds after denosumab? small study tests timing
Disease control CompletedThis study looked at 45 people with osteoporosis caused by long-term steroid use. Participants had stopped taking denosumab and were switched to either zoledronic acid or alendronate at different times. The goal was to see which timing and drug best controlled bone loss markers. …
Matched conditions: GLUCOCORTICOID-INDUCED OSTEOPOROSIS
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC